Leverage Risk

Overview

Leverage increases economic exposure relative to the capital supporting a position. It can arise through loans, margin trading, derivatives, rehypothecation, structured products, or protocols that allow repeated borrowing against interconnected collateral.

Small price movements can cause disproportionate equity loss, forced liquidation, or cascading market impact. Effective leverage may exceed reported borrowing when guarantees, derivatives, liquidity commitments, or correlated positions remain outside a simple balance calculation.

Risk controls include conservative limits, collateral haircuts, margin monitoring, stress tests, concentration analysis, liquidity planning, and restrictions on recursive borrowing. Models should include price gaps, oracle failure, delayed liquidation, and market depth during stress. Leverage calculations should include contingent obligations and economically equivalent synthetic exposure.

Leverage risk is the possibility that borrowed funds or derivative exposure magnifies losses, margin demands, liquidation, or insolvency. Leverage multiplies both exposure and speed of loss, making collateral quality, liquidity, margin, concentration, and stress behavior essential.

For Leverage Risk, the assessment should evaluate the possibility that borrowed funds or derivative exposure magnifies losses, margin demands, liquidation, or insolvency. The assessment record should separate observed evidence supporting the possibility that borrowed funds or derivative exposure magnifies losses, margin demands, liquidation, or insolvency from assumptions, state the time horizon and existing controls, and identify who owns any remaining exposure. Monitoring should test whether the conditions described in the possibility that borrowed funds or derivative exposure magnifies losses, margin demands, liquidation, or insolvency have changed enough to require a new rating, treatment, or approval.

Decision-makers should use findings about the possibility that borrowed funds or derivative exposure magnifies losses, margin demands, liquidation, or insolvency to select treatment, assign remediation, set review thresholds, and document why any residual exposure is accepted.